HOME >> MEDICINE >> NEWS
A threatened St. Johns wort plant could be more effective as an anti-depressant, Cornell and USDA researchers find

ver, not all St. John's wort products are the same. Previous studies have shown that the amount of hypericin in the plant - although usually labeled can vary from plant to plant, manufacturer to manufacturer, bottle to bottle and pill to pill. Thus Sirvent and Gibson are trying to determine how much of a role pre-harvest factors play in chemical differences. They are examining factors such as light, moisture, altitude and latitude; the plant parts; the plant's development stage; and the harvesting and handling practices that might affect the quality of the final product. Additionally, variations in St. John's wort products sometimes occur because manufacturers mix species of H. perforatum.

The plant typically is gathered as a weedy species in the western United States, but some is being grown commercially in the Pacific Northwest. It also is found along roadways and in fields in the eastern United States. Hypericin is concentrated in little black nodules nearly imperceptible to the untrained eye that adorn the floral edges and the plant's leaves. Curiously, St. John's wort is considered a noxious weed that can cause hypericism, or blistering and dyeing of an animal's skin when it is eaten. Its scraggly, almost frail-looking stem produces a brilliant yellow flower cluster and it grows readily in rock quarries and in marginal areas such as roadsides, where little else grows.


'"/>

Contact: Blaine Friedlander
bpf2@cornell.edu
607-255-3290
Cornell University News Service
14-Aug-2000


Page: 1 2

Related medicine news :

1. Caregivers refuse Alzheimers medications when patients quality of life threatened
2. Johns Hopkins scientists receive presidential medals
3. Robert Wood Johnson Medical School researcher receives fellowship for work in Canavan Disease
4. Rutgers announces Robert Wood Johnson Foundation Investigator Awards in Health Policy Research
5. Federal institutes and the Robert Wood Johnson Foundation create Tobacco Use Research Centers
6. Johns Hopkins To Announce AIDS Capitated Care Program
7. Success of liver transplantation may be most influenced by three risk factors
8. Tracking trends in cochlear implant complications using a federal database
9. Alcohol relapse adversely affects 10-year liver transplant survival
10. Donor age has no affect on long-term liver transplant survival
11. Age shouldnt be a factor in kidney transplantation

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
Breaking Medicine Technology:
Cached News: